Citation Impact
Citing Papers
Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin
2009
Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis
2009
Human Papillomaviruses and the Interferon Response
2009
Treatment of kidney cancer
2009 StandoutNobel
Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations
2007 StandoutNobel
The DNA-damage response in human biology and disease
2009 StandoutNature
Molecular pathways executing the “trophic sentinel” response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation
2003
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
E2F target genes and cell-cycle checkpoint control
1999
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
2000
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Classification of papillomaviruses
2004 StandoutNobel
Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins
2007
Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes
1999 StandoutNobel
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Head and neck cancer
2008 Standout
Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins
2009
Viruses in human cancers
1999 StandoutNobel
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
2002 Standout
Three Different Binding Sites of Cks1 Are Required for p27-Ubiquitin Ligation
2002 StandoutNobel
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
1997
The Epigenomics of Cancer
2007 Standout
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
2000 StandoutNobel
Oncogenic activities of human papillomaviruses
2009
dpl-1 DP and efl-1 E2F Act with lin-35 Rb to Antagonize Ras Signaling in C. elegans Vulval Development
2001 StandoutNobel
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
1997
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue
2000 StandoutNobel
The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix
1998 StandoutNobel
Cancer genes and the pathways they control
2004 Standout
Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex
1999
The human papillomavirus E7 oncoprotein
2008
Viruses in human cancers
1999 StandoutNobel
von Hippel-Lindau disease
2003 Standout
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
p21 in cancer: intricate networks and multiple activities
2009 Standout
Regulation of cancer cell metabolism
2011 Standout
Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent Manner
2002
Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP‐3
2005
Human papillomavirus and cervical cancer
2007 Standout
Human papillomavirus immortalization and transformation functions
2002
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Human Papillomavirus Types 16 E6 and E7 Contribute Differently to Carcinogenesis
2000
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections
2002
The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27
2001 StandoutNobel
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
2001
The role of human papillomavirus oncoproteins E6 and E7 in apoptosis
2002
Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor
2001 StandoutNobel
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes
2008
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression
2001 StandoutNobel
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins
2003
A Novel Human DnaJ Protein, hTid-1, a Homolog of the Drosophila Tumor Suppressor Protein Tid56, Can Interact with the Human Papillomavirus Type 16 E7 Oncoprotein
1998
Reduced Expression of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) in Squamous Cell Carcinoma Complicating Recessive Dystrophic Epidermolysis Bullosa
2004
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis
2002 StandoutNobel
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins
2006
Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation
2005
Mechanisms of Human Papillomavirus-Induced Oncogenesis
2004
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus
2007
Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Centrosomal Component γ-Tubulin
2007
Disruption of the G 1 /S Transition in Human Papillomavirus Type 16 E7-Expressing Human Cells Is Associated with Altered Regulation of Cyclin E
1998
Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation
1998
The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
1998
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
1999 StandoutScienceNobel
The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.
2002
Human Papillomavirus Type 16 E7 Oncoprotein Can Induce Abnormal Centrosome Duplication through a Mechanism Independent of Inactivation of Retinoblastoma Protein Family Members
2003
Modulation of type M 2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein
1999
The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals
1999
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
1998
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Papillomavirus E6 and E7 proteins and their cellular targets
2007
Control of interferon signaling in human papillomavirus infection
2001
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
2007 StandoutNobel
A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies
2003 StandoutNobel
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
1999 StandoutNobel
Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6
2008
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7
2003
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Induction of apoptosis in cervical carcinoma cells by peptide aptamers that bind to the HPV‐16 E7 oncoprotein
2001
RBP1 Recruits Both Histone Deacetylase-Dependent and -Independent Repression Activities to Retinoblastoma Family Proteins
1999 StandoutNobel
Works of Boris Mannhardt being referenced
Allosteric Activation of Acid α-Glucosidase by the Human Papillomavirus E7 Protein
2000
Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.
1996
Anchorage-Independent Transcription of the Cyclin A Gene Induced by the E7 Oncoprotein of Human Papillomavirus Type 16
1998
Human Papillomavirus Type 16 E7 Oncoprotein Binds and Inactivates Growth-Inhibitory Insulin-Like Growth Factor Binding Protein 3
2000